Stocks are ready for a stronger opening on Wednesday after a choppy start to a week cut short by holidays. Due to the fact that many participants are still on holiday and there aren’t many catalysts, volume is probably going to remain low. Here are a few stocks to watch on Wednesday:
Stocks to Watch
- The quantity of iPhone 14 Pro shipments predicted by Trendforce for Apple (NASDAQ:AAPL) in 2022 has decreased. As the IT giant struggled with a labor shortage in China, the research firm now claims that 78.1M units of the product were sold during the year. The Q1 projection from Trendforce was likewise reduced. With the most recent relaxation of travel restrictions and downgrading of COVID-19 to a Category B virus, China has continued to roll back many of its rigorous zero-COVID regulations in recent days. The “closed-loop” system that had been in place at Foxconn’s factory in Zhengzhou, China, had been removed, the company announced earlier this month.
- The U.S. Food and Drug Administration has approved the pentavalent meningococcal vaccine candidate from Pfizer (NYSE:PFE) for assessment. PFE’s application will be decided upon by the FDA in October 2023.
- According to a study conducted in Australia, the Novavax (NASDAQ:NVAX) protein-based COVID vaccine is less effective than mRNA-based vaccinations. According to the research, which was supported by the New South Wales Ministry of Health, patients who received the NVX had greater rates of COVID infection than those who received competing vaccinations.
- Bill Mulligan, an outside professional, has been chosen as CEO of Maxeon Solar Technologies (NASDAQ:MAXN). At Sila Nanotechnologies, Mulligan previously held the position of COO. In the meanwhile, Mark Babcock, the temporary CEO, will resume his responsibilities as a chief revenue officer.
Featured Image: Pexels @ Anna Tarazevich
Author Jowi Kwasu 
